Aurora Polska sp. z o.o.

Manufacture of basic pharmaceutical products

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2019-01-24
Share capital
5,000.00 PLN
Activity description

Aurora Polska is one of the leading producers of medical cannabis and acts as a professional partner for physicians and other medical specialists. Through its Aurora Academy platform, it offers lectures and educational materials on therapy, not only product-related. Publications are regularly expanded with Canadian and Western European materials.

Registered address
ul. Prosta 51, 00-838 Warszawa, Poland
Phone
Social media
Electronic delivery address
AE:PL-73828-47119-RWEDC-19

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$51,969
Profit allocationRetained in reserve capital
Loans and borrowings$74,378
Foreign sales99.98% of revenue ($2,237,355)
Revenue structureUsługi wspierające sprzedaż produktów Aurora Europe
Future lease and rent payments$310,756

Filing timeliness

No financial statement for 2026 – the filing deadline has passed.

  • 2026not filed
  • 202530/09/2025
  • 202318/12/2023
  • 202212/10/2022
  • 202115/10/2021
  • 201909/10/2020
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Sector · Manufacturing10,698 / 33,822
Top 32%
Voivodeship · Mazowieckie20,815 / 142,204
Top 15%
Country · Poland75,536 / 496,474
Top 15%

Results vs industry

Revenue
This companyUSD 2.25mMedianUSD 165.97kAverageUSD 2.30m
Net profit
This companyUSD 99.18kMedianUSD 1.32kAverageUSD 109.80k
Operating costs
This companyUSD 2.09mMedianUSD 201.81kAverageUSD 2.10m
Assets
This companyUSD 438.99kMedianUSD 118.27kAverageUSD 1.54m

Websites

Authorized Representatives

Radzisław Jerzy Elias age 54 – Management Board Member

Manner of representation

In the case of a one-person management board, the only member of the management board is authorised to make declarations of will on behalf of the company independently. If the management board is multi-member, each member of the management board is authorised to make declarations of will on behalf of the company independently; however, for legal acts concerning liabilities or dispositions exceeding PLN 30,000.00 (thirty thousand zloty), joint action by two members of the management board is required.

Ownership

OwnerSharesShare valueStake
Aurora Europe Gmbh
100$1,350.62100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2019-03-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Vitama S.A.
Cosma S.A.
Ever Pharma Poland sp. z o.o.
Almirall sp. z o.o.
Bioactive T sp. z o.o.
Przedsiębiorstwo Farmaceutyczne Sulphur Busko Zdrój sp. z o.o.
Grand Medical Poland sp. z o.o.
Ecoversea sp. z o.o.
Goodwill Pharma Polska sp. z o.o.
Unipharm sp. z o.o.

Change history

DateEvent
2025-01-31Address change
2024-11-04Address change
2023-09-25Address change
2022-10-27Address change
2019-01-24Entered in the register

FAQ

Last updated: 2026-10-05